{
  "drug_name": "Metronidazole",
  "url": "https://wikem.org/wiki/Metronidazole",
  "scraped_at": "2026-01-10T02:46:11.979790",
  "sections": {
    "General": "Type: Other\nantibiotics\nDosage Forms:\nIV\nPO: 250mg; 375mg; 500mg\nCommon Trade Names: Flagyl",
    "Adult_Dosing": "General\nPO\n500mg PO q6-8h x 7-10 days\nFirst Dose: 500mg PO x 1\nIV\n15mg/kg IV x1, then 7.5mg/kg IV q6h\nFirst Dose: 15mg/kg IV x1\nMax: 1 gram/dose\nAmebic liver abscess\n500-750mg PO q8h x 5-10 days\nColorectal Surgery Infection Prophylaxis\n15mg/kg IV x 1\nComplete infusion 1h prior to surgery, then 7.5mg/kg IV q6h x 2\nMax: 1 g/dose\nIntestinal\nAmebiasis\n750mg PO q8h x 5-10 days\nPID\n500mg PO q12 x 14 days\nSee\nPID\nfor full regimen\nBacterial Vaginosis\n500mg PO q12 x 7 days\nAlt: May use 250mg PO q8h x 7 days in pregnant patients\nProphylaxis (\nSexual Assault\n)\n2 g PO x 1\nTrichomoniasis\nTreatment\nImmunocompetent: 2 g PO x 1\nImmunocompromised: 500mg PO q12h x 7 days\nProphylaxis (\nSexual Assault\n)\n2 g PO x 1\nGiardiasis\n250mg PO q8h x 5-7 days\nAlt: 2 g PO q 24h x 3 days\nC. Difficile\nMild-mod\n500mg PO q8h x 10-14 days\nSevere\n500mg IV q8h (give with\nvancomycin\nPO)\nH. pylori\n250-375mg PO q6h x 10-14 days (in combination)\nUrethritis\n, recurrent/persistent (Non-Gonococcal)\n2 g PO x 1 (with azithromycin)\nTetanus\n500 mg  IV every 6 hours",
    "Pediatric_Dosing": "(<1200g)\n7.5 mg/kg PO/IV q48h\nFirst Dose: 7.5 mg/kg PO/IV x 1\n(>1200g AND <1 Month Old)\n<7 days old\n7.5-15 mg/kg/day PO/IV q12-24h\nFirst Dose: 7.5-15 mg/kg PO/IV x 1\n>7 days old\n15-30 mg/kg/day PO/IV q12h\nFirst Dose: 7.5-15 mg/kg PO/IV x 1\n(>1 Month Old)\n30 mg/kg/day PO/IV q6h\nFirst Dose: 7.5 mg/kg PO/IV x 1\nMax: 4 g/day\nBacterial Vaginosis\n<45kg\n15 mg/kg/day PO divided q12h x 7 days\nFirst Dose: 7 mg/kg PO x 1\nMax: 1 g/day\n>45kg\n500mg PO divided q8h x 7 days\nFirst Dose: 500mg PO x 1\nMax: 2 g/day\nProphylaxis (sexual Assault)\n<45kg'\n15 mg/kg/day PO divided q8h x 7 days\nFirst Dose: 7 mg/kg PO x 1\n>45kg\n2 g PO x 1\nTetanus\nSame as\nStandard Pediatric Age/Weight Dosing",
    "Special_Populations": "Pregnancy:\nB\nLactation: Safety conditional\nRenal Dosing\nAdult\nNo adjustment for renal insufficiency\nHemodialysis: Give dose after dialysis\nPeritoneal Dialysis: No supplement\nPediatric\nCrCl <10: Decrease dose 50%\nHemodialysis: Give dose after dialysis\nPeritoneal Dialysis: No supplement\nHepatic Dosing (Adult & Pediatric)\nSevere impairment: decrease dose, amount not defined",
    "Contraindications": "Black Box: carcinogenic in mice and rats; avoid unnecessary use; reserved for approved conditions\nAllergy to class/drug\nPregnancy (single 2 dose retimen)\nAlcohol use within 3 days\nDisulfiram use within 14 days",
    "Adverse_Reactions": "Serious\nSeizures\nAseptic\nmeningitis\nPerifpheral neuropathy\nOptic neuropathy\nEncephalopathy\nHypersensitivity Reaction\nStevens-Johnson Syndrome\nToxic Epidermal Necrolysis\nLeukopenia\nCarcinogenicity (in animals)\nCommon\nDisulfiram effect\n(should abstain from ETOH at least two days after last dose)\nNausea and Vomiting\nEpigastric discomfort\nDiarrhea\nMetallic taste\nRash\nHeadache\nDizziness\nDark reddish-brown urine\nCandidiasis\nThrombophlebitis (IV use)",
    "Pharmacology": "Half-life: 8h\nMetabolism: Liver; CYP450: 2C9 inhibitor\nExcretion: Urine (70%); feces (15%)\nMechanism of Action: Bactericidal"
  }
}